Ray Dalio
NUS icon

Ray Dalio’s Nu Skin NUS Stock Holding History

Ray Dalio’s Portfolio NUS Stock Details NUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-32,402
Closed -$239K – 793
2024
Q3 		$239K Sell
32,402
-36,188
-53% -$338K ﹤0.01% 759
2024
Q2 		$723K Sell
68,590
-10,300
-13% -$131K ﹤0.01% 709
2024
Q1 		$1.09M Sell
78,890
-12,046
-13% -$188K 0.01% 563
2023
Q4 		$1.77M Sell
90,936
-28,964
-24% -$535K 0.01% 536
2023
Q3 		$2.54M Buy
119,900
+23,639
+25% +$614K 0.02% 467
2023
Q2 		$3.2M Sell
96,261
-3,596
-4% -$132K 0.02% 390
2023
Q1 		$3.93M Sell
99,857
-18,286
-15% -$760K 0.02% 361
2022
Q4 		$4.98M Sell
118,143
-20,485
-15% -$788K 0.03% 362
2022
Q3 		$4.63M Sell
138,628
-41,545
-23% -$1.73M 0.02% 397
2022
Q2 		$7.8M Buy
180,173
+45,959
+34% +$2.11M 0.03% 388
2022
Q1 		$6.43M Buy
134,214
+31,840
+31% +$1.58M 0.03% 401
2021
Q4 		$5.2M Buy
102,374
+16,218
+19% +$721K 0.03% 289
2021
Q3 		$3.49M Buy
86,156
+2,277
+3% +$115K 0.02% 347
2021
Q2 		$4.75M Buy
+83,879
New +$4.77M 0.03% 338

Other funds holding NUS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Ray Dalio's NUS Position: Q4 2024 in Review

Ray Dalio sold out of Nu Skin (NUS) in Q4 2024, closing a stake of 32,402 shares — an estimated $239K sold.

Ray Dalio first reported a position in NUS in Q2 2021 and held it in 14 quarters. The position peaked at $7.8M in Q2 2022. 200 funds tracked by Wall St. Rank hold NUS as of Q4 2024.

  • Ray Dalio reported no remaining Nu Skin position as of Q4 2024 after selling out during the quarter.
  • Ray Dalio sold 32,402 Nu Skin shares in Q4 2024, an estimated $239K.
  • Ray Dalio first reported a position in Nu Skin in Q2 2021 and held it in 14 quarters.
  • Ray Dalio's Nu Skin position peaked at $7.8M in Q2 2022.
  • 200 funds tracked by Wall St. Rank held Nu Skin as of Q4 2024.

Based on Bridgewater Associates's 13F filing for Q4 2024, filed 13 Feb 2025.